RecruitingNot ApplicableNCT04298255

Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples


Sponsor

Wake Forest University Health Sciences

Enrollment

50 participants

Start Date

Aug 24, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to evaluate if special types of cells called round spermatids can be gathered from men with non-obstructive azoospermia and used (in absence of elongated spermatids and spermatozoa) to reliably and effectively create pregnancy with a procedure called Round Spermatid Injection (ROSI). This process is similar to In Vitro Fertilization, or 'IVF'. In addition, this study wants to test the safety of ROSI and see what effects (good and bad) it has on embryo created from this method.


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria4

  • Males with no elongated spermatids or spermatozoa present but with round spermatids present on TESE (Testicular Sperm Extraction)
  • Male diagnosed with non-obstructive Azoospermia
  • Male partner ≥18
  • Female partner greater than 18 years of age and less than 38 years of age or Anti Mullerian Hormone (AMH) greater than 2 ng/ml.

Exclusion Criteria2

  • Males with obstructive azoospermia
  • Males with presence an adequate number of elongated spermatids or spermatozoa

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERRound Spermatid Injection (ROSI)

In Vitro Fertilization using Round Spermatid Injection (ROSI)

OTHERHalf ROSI-half Sperm Donor Fertilization

Half ROSI-half Sperm Donor Fertilization


Locations(1)

Carolinas Fertility Institute (CFI)

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04298255


Related Trials